Jeang K.-T.LI-MIN HUANG2021-06-242021-06-2420090929-6646https://www.scopus.com/inward/record.uri?eid=2-s2.0-71649101281&doi=10.1016%2fS0929-6646%2809%2960412-5&partnerID=40&md5=00a4ddf9fd44649d26b65bd25d02bf6bhttps://scholars.lib.ntu.edu.tw/handle/123456789/566529[SDGs]SDG3glycoprotein gp 120; glycoprotein gp 41; Human immunodeficiency virus vaccine; placebo; acquired immune deficiency syndrome; article; clinical trial; health program; human; Human immunodeficiency virus 1; Human immunodeficiency virus infection; infection prevention; Thailand; treatment failure; AIDS Vaccines; Clinical Trials as Topic; HIV-1; Humansjournal article10.1016/S0929-6646(09)60412-5199330242-s2.0-71649101281